First New Inhaled Anti-Pseudomonal Therapy Approved for Cystic Fibrosis Patients in More Than 10 Years
U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa
http://www.gilead.com/pr_1393831
For all my buddies who couldn’t qualify for the study or the ‘compassionate care’ program, it’s your time now!!!
(now for the fight for insurance coverage… fun fun!)
If you liked my post, feel free to subscribe to my rss feeds



























BlogoSquare
3 Comments so far (Add 1 more)